UnitedHealth Group said consolidated revenues for Q1 2025 grew 10%, UnitedHealthcare revenues grew 12% and Optum revenues grew 5%. Consolidated earnings from operations were $9.1 billion, compared with $7.9 billion in the prior-year quarter, and the company said 2024 was impacted by the Change Healthcare cyberattack.

10-QQuarterly reportFiled May 7, 2025Period of report Mar 31, 2025Summary published (UTC) Oct 10, 2026

Key points

AI summary

UnitedHealth Group said consolidated revenues for Q1 2025 grew 10%, UnitedHealthcare revenues grew 12% and Optum revenues grew 5%. Consolidated earnings from operations were $9.1 billion, compared with $7.9 billion in the prior-year quarter, and the company said 2024 was impacted by the Change Healthcare cyberattack.
The company cited growth in Medicare Advantage and domestic commercial offerings, the impact of the Inflation Reduction Act on Medicare Part D and elevated care patterns for seniors served through Medicare Advantage as factors in the increase in medical costs. It said the medical care ratio increased as a result of the revenue effects of Medicare funding reductions and other factors.
UnitedHealth Group said Optum Health revenues and earnings from operations both decreased, citing the conversion of risk-based contracts and Medicare Advantage funding reductions as factors in the revenue decline. Optum Rx revenues and earnings from operations increased, and the company said adjusted scripts were 408 million for Q1 2025 and 395 million for Q1 2024.
The company said cash flows from operations for the 3 months ended March 31, 2025 were $5.5 billion. During the same period, it repurchased approximately 6.0 million shares at an average price of $503.72 per share, and as of March 31, the Board of Directors' authorization to purchase shares was 27 million shares.

Key figures

Quarter ended March 31, 2025

Revenue: $109.6B
Operating income: $9.1B
Net income: $6.3B
EPS: $6.85
Operating cash flow: $5.5B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q1 2025 Consolidated Revenues and Operating Earnings

UnitedHealth Group said consolidated revenues for Q1 2025 grew 10%, UnitedHealthcare revenues grew 12% and Optum revenues grew 5%. Consolidated earnings from operations were $9.1 billion, compared with $7.9 billion in the prior-year quarter, and the company said 2024 was impacted by the Change Healthcare cyberattack.

Source · Based on the MD&A text of the filing

Medicare Advantage Medical Costs and Medical Care Ratio Factors

The company cited growth in Medicare Advantage and domestic commercial offerings, the impact of the Inflation Reduction Act on Medicare Part D and elevated care patterns for seniors served through Medicare Advantage as factors in the increase in medical costs. It said the medical care ratio increased as a result of the revenue effects of Medicare funding reductions and other factors.

Source · Based on the MD&A text of the filing

Optum Health and Optum Rx Segment Results

UnitedHealth Group said Optum Health revenues and earnings from operations both decreased, citing the conversion of risk-based contracts and Medicare Advantage funding reductions as factors in the revenue decline. Optum Rx revenues and earnings from operations increased, and the company said adjusted scripts were 408 million for Q1 2025 and 395 million for Q1 2024.

Source · Based on the MD&A text of the filing

Q1 2025 Operating Cash Flows and Share Repurchases

The company said cash flows from operations for the 3 months ended March 31, 2025 were $5.5 billion. During the same period, it repurchased approximately 6.0 million shares at an average price of $503.72 per share, and as of March 31, the Board of Directors' authorization to purchase shares was 27 million shares.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.